FTC Sues to Block Illumina’s Deal for Grail in Antitrust Test

The Federal Trade Commission said it would seek to block Illumina’s planned $7.1 billion acquisition of a developer of a long-sought blood test that promises to detect cancer early.

HUD Aims to Boost Homeownership for Buyers With Higher Student Debt

A relaxed student-loan calculation will likely qualify more Black and Hispanic...

Top Bankruptcy Firm Kirkland Losing Lawyers as Economy Improves

Kirkland & Ellis LLP and several attorneys from the law firm’s...

Lobbyists for Silicon Valley Giants Find Glory Days Are Over

Lobbyists representing large tech companies such as Facebook are facing a...

Thieves Find Money That Grows on Trees: ‘Avocados Are the Green Gold’

Global demand has spurred brazen nighttime heists and defensive measures from...